Wolfgang E. Reintsch

3801 University Street
Montreal, QC H3A2B4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

BetaII-spectrin gaps and patches emerge from the patterned assembly of the actin/spectrin membrane skeleton in human motor neuron axons.

BetaII-spectrin gaps and patches emerge from the patterned assembly of the actin/spectrin membrane skeleton in human motor neuron axons.

Journal: eLife

Published: September 08, 2026

An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neurons.

An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neurons.

Journal: Methods (San Diego, Calif.)

Published: February 06, 2026

A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils.

A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils.

Journal: Methods (San Diego, Calif.)

Published: February 06, 2026

Evaluation of Additive Neuroprotective Effect of Combination Therapy for Parkinson's Disease Using In Vitro Models.

Evaluation of Additive Neuroprotective Effect of Combination Therapy for Parkinson's Disease Using In Vitro Models.

Journal: Antioxidants (Basel, Switzerland)

Published: February 24, 2025

Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of α-synuclein fibrils.

Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of α-synuclein fibrils.

Journal: Communications biology

Published: December 24, 2024

Multiplex Immunofluorescent Batch Labeling of Marmoset Brain Sections.

Multiplex Immunofluorescent Batch Labeling of Marmoset Brain Sections.

Journal: Brain and behavior

Published: September 09, 2024

Combination of tauroursodeoxycholic acid, co-enzyme Q10 and creatine demonstrates additive neuroprotective effects in in-vitro models of Parkinson's disease.

Combination of tauroursodeoxycholic acid, co-enzyme Q10 and creatine demonstrates additive neuroprotective effects in in-vitro models of Parkinson's disease.

Journal: Frontiers in neuroscience

Published: September 06, 2024

Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications.

Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications.

Journal: eLife

Published: November 23, 2023

Transcriptional Dysregulation and Impaired Neuronal Activity in FMR1 Knock-Out and Fragile X Patients' iPSC-Derived Models.

Transcriptional Dysregulation and Impaired Neuronal Activity in FMR1 Knock-Out and Fragile X Patients' iPSC-Derived Models.

Journal: International journal of molecular sciences

Published: August 31, 2023

Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications.

Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2023

An Optimized Workflow to Generate and Characterize iPSC-Derived Motor Neuron (MN) Spheroids.

An Optimized Workflow to Generate and Characterize iPSC-Derived Motor Neuron (MN) Spheroids.

Journal: Cells

Published: January 04, 2023

Rapid macropinocytic transfer of α-synuclein to lysosomes.

Rapid macropinocytic transfer of α-synuclein to lysosomes.

Journal: Cell reports

Published: December 29, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026